论文部分内容阅读
目的了解对我院慢性支气管炎的治疗效果及其相关影响因素,为预防和控制慢性支气管炎提供科学的理论依据。方法采用整群随机抽样的方法,随机抽取在我医院住院的慢性支气管炎患者60人为调查对象,匹多莫德治疗组和常规治疗对照组各为30人,观察治疗效果。结果匹多莫德治疗组总有效率达到91.67%,而对照组达到60.42%,两组治疗效果差异有统计学意义(P<0.05),匹多莫德治疗组效果好于传统治疗。两组病例治疗过程中未出现明显不良反应。老年人慢性支气管炎影响因素是感染、病程、吸烟、抗生素使用种类。结论匹多莫德治疗慢性支气管炎具有较好临床疗效,只有医护人员熟练掌握治疗方法和相关技能,才能取得较好的临床效果。
Objective To understand the therapeutic effect of chronic bronchitis and its related factors in our hospital and provide a scientific theoretical basis for the prevention and control of chronic bronchitis. Methods A total of 60 patients with chronic bronchitis hospitalized in our hospital were randomly selected from the randomized cluster sampling study. Podeodymide group and routine treatment control group were 30, and the therapeutic effect was observed. Results The total effective rate of pidotimod group was 91.67%, while the control group reached 60.42%. The difference between the two groups was statistically significant (P <0.05). Pidotimod group was better than the traditional treatment. Two groups of patients did not appear during the treatment of significant adverse reactions. The influencing factors of chronic bronchitis in the elderly are infection, course of disease, smoking, types of antibiotics used. Conclusion Pidotimod treatment of chronic bronchitis has a good clinical efficacy, only medical personnel mastering the treatment methods and related skills in order to achieve better clinical results.